kt 6149 has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saijo, N | 1 |
| Ashizawa, T; Azuma, M; Gomi, K; Kanda, Y; Kobayashi, E; Kono, M; Morimoto, M; Ohno, H; Okabe, M; Saitoh, Y | 1 |
1 review(s) available for kt 6149 and Experimental Neoplasms
| Article | Year |
|---|---|
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
1 other study(ies) available for kt 6149 and Experimental Neoplasms
| Article | Year |
|---|---|
Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Division; Drug Administration Schedule; Drug Resistance; Hematopoiesis; Humans; Mice; Mice, Nude; Mitomycins; Neoplasm Transplantation; Neoplasms, Experimental; Structure-Activity Relationship | 1991 |